Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Pfizer closes R&D unit that spawned $7.1B anti-TL1A med
The now-shuttered R&D subunit helped spawn new medicines, including Roivant's $7.1 billion anti-TL1A med.
Max Bayer
Apr 17, 2024 7:00am
Lilly glides out of Leqembi slipstream with FDA meeting request
Apr 17, 2024 5:00am
Biotech naming trends bypass 'buzzwords and business speak'
Apr 16, 2024 8:30am
23andMine: Anne Wojcicki aims to take genetics company private
Apr 18, 2024 9:16am
AbbVie-bound Cerevel reports phase 3 Parkinson's victory
Apr 18, 2024 8:34am
Arch-backed obesity biotech launches with $290M
Apr 18, 2024 7:00am
Medtech News
FDA hands de novo clearance to Scopio's bone marrow pathology AI
Apr 17, 2024 12:56pm
Abbott medical device gains drive nearly $10B quarterly haul
Apr 17, 2024 11:37am
J&J CEO says M&A strategy to 'continue' after medtech megadeals
Apr 16, 2024 1:42pm
PacBio plots budget cuts after DNA sequencing sales shortfalls
Apr 16, 2024 11:44am
See More Medtech News